Laurent Dercle
Laurent Dercle
NewYork-Presbyterian Hospital - Columbia University Irving Medical Center
Verified email at cumc.columbia.edu
Title
Cited by
Cited by
Year
Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1
S Champiat, L Dercle, S Ammari, C Massard, A Hollebecque, ...
Clinical Cancer Research 23 (8), 1920-1928, 2017
7232017
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
R Sun, EJ Limkin, M Vakalopoulou, L Dercle, S Champiat, SR Han, ...
The Lancet Oncology 19 (9), 1180-1191, 2018
3402018
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
EJ Limkin, R Sun, L Dercle, EI Zacharaki, C Robert, S Reuzé, ...
Annals of Oncology 28 (6), 1191-1206, 2017
2582017
18F-FDG PET and CT scans detect new imaging patterns of response and progression in patients with Hodgkin lymphoma treated by anti–programmed death 1 immune checkpoint inhibitor
L Dercle, RD Seban, J Lazarovici, LH Schwartz, R Houot, S Ammari, ...
Journal of Nuclear Medicine 59 (1), 15-24, 2018
742018
Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners
S Reuzé, F Orlhac, C Chargari, C Nioche, E Limkin, F Riet, A Escande, ...
Oncotarget 8 (26), 43169, 2017
742017
Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
A Mekki, L Dercle, P Lichtenstein, A Marabelle, JM Michot, O Lambotte, ...
European Journal of Cancer 96, 91-104, 2018
662018
Radiomics in nuclear medicine applied to radiation therapy: methods, pitfalls, and challenges
S Reuzé, A Schernberg, F Orlhac, R Sun, C Chargari, L Dercle, E Deutsch, ...
International Journal of Radiation Oncology* Biology* Physics 102 (4), 1117-1142, 2018
452018
Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence
L Dercle, S Ammari, M Bateson, PB Durand, E Haspinger, C Massard, ...
Scientific reports 7 (1), 1-10, 2017
442017
Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody
JM Michot, R Mazeron, L Dercle, S Ammari, C Canova, A Marabelle, ...
European Journal of Cancer 66, 91-94, 2016
422016
New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value
T Cognet, PL Vervueren, L Dercle, D Bastié, R Richaud, M Berry, ...
Cardiovascular diabetology 12 (1), 1-12, 2013
392013
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
RD Seban, JS Nemer, A Marabelle, R Yeh, E Deutsch, S Ammari, ...
European journal of nuclear medicine and molecular imaging 46 (11), 2298-2310, 2019
382019
Diagnostic performance of 4D CT and sestamibi SPECT/CT in localizing parathyroid adenomas in primary hyperparathyroidism
R Yeh, YKD Tay, G Tabacco, L Dercle, JH Kuo, L Bandeira, C McManus, ...
Radiology 291 (2), 469-476, 2019
362019
Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy
L Dercle, S Ammari, S Champiat, C Massard, C Ferté, L Taihi, RD Seban, ...
European journal of cancer 65, 33-42, 2016
362016
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
RD Seban, L Mezquita, A Berenbaum, L Dercle, A Botticella, ...
European journal of nuclear medicine and molecular imaging, 1-11, 2019
312019
Radiomics response signature for identification of metastatic colorectal cancer sensitive to therapies targeting EGFR pathway
L Dercle, L Lu, LH Schwartz, M Qian, S Tejpar, P Eggleton, B Zhao, ...
JNCI: Journal of the National Cancer Institute 112 (9), 902-912, 2020
282020
Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules
FZ Mokrane, L Lu, A Vavasseur, P Otal, JM Peron, L Luk, H Yang, ...
European radiology 30 (1), 558-570, 2020
272020
The role of 18F-FDG PET/CT and PET/MRI in pancreatic ductal adenocarcinoma
R Yeh, L Dercle, I Garg, ZJ Wang, DM Hough, AH Goenka
Abdominal Radiology 43 (2), 415-434, 2018
272018
CT slice thickness and convolution kernel affect performance of a radiomic model for predicting EGFR status in non-small cell lung cancer: a preliminary study
Y Li, L Lu, M Xiao, L Dercle, Y Huang, Z Zhang, LH Schwartz, D Li, B Zhao
Scientific reports 8 (1), 1-10, 2018
252018
Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)
R Sun, S Champiat, L Dercle, S Aspeslagh, E Castanon, EJ Limkin, ...
European Journal of Cancer 84, 202-211, 2017
252017
Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma
L Dercle, S Ammari, RD Seban, LH Schwartz, R Houot, N Labaied, ...
European Journal of Cancer 91, 136-144, 2018
242018
The system can't perform the operation now. Try again later.
Articles 1–20